Published in Clin Transplant on August 03, 2009
Arboviral encephalitides: transmission, emergence, and pathogenesis. J Neuroimmune Pharmacol (2010) 1.24
A review of the epidemiological and clinical aspects of West Nile virus. Int J Gen Med (2014) 1.02
Clinical and radiological predictors of outcome for Murray Valley encephalitis. Am J Trop Med Hyg (2013) 0.89
West Nile Virus Central Nervous System Infection in Patients Treated With Rituximab: Implications for Diagnosis and Prognosis, With a Review of Literature. Open Forum Infect Dis (2015) 0.83
Neurological complications of solid organ transplantation. Neurohospitalist (2013) 0.80
West Nile Virus Infection in the Immunocompromised Patient. Curr Infect Dis Rep (2013) 0.79
Delayed-onset flaccid paralysis related to west Nile virus reactivation following treatment with rituximab: a case report. BMC Res Notes (2014) 0.75
Fatal Eastern Equine Encephalitis in a Patient on Maintenance Rituximab: A Case Report. Open Forum Infect Dis (2017) 0.75
IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood (1997) 4.97
Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med (2003) 4.95
B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol (2003) 4.87
Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med (1998) 3.76
A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med (2003) 2.89
Virus and antibody dynamics in acute west nile virus infection. J Infect Dis (2008) 2.84
Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol (2004) 2.71
Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation (2004) 2.11
RS-61443--a phase I clinical trial and pilot rescue study. Transplantation (1992) 1.97
A unique cell surface antigen identifying lymphoid malignancies of B cell origin. J Clin Invest (1981) 1.93
West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review. Clin Infect Dis (2004) 1.84
Protective anti-reovirus monoclonal antibodies and their effects on viral pathogenesis. J Virol (1993) 1.55
Immunopathology of flavivirus infections. Immunol Cell Biol (2006) 1.52
First Isolation of West Nile virus from a patient with encephalitis in the United States. Emerg Infect Dis (2002) 1.50
A seroprevalence study of west nile virus infection in solid organ transplant recipients. Am J Transplant (2004) 1.09
Fatal West Nile virus encephalitis in a renal transplant recipient. Am J Clin Pathol (2004) 1.06
Fatal West Nile Virus infection after rituximab/fludarabine--induced remission for non-Hodgkin's lymphoma. Clin Lymphoma Myeloma (2005) 0.94
Pulmonary capillaritis in lung transplant recipients: treatment and effect on allograft function. J Heart Lung Transplant (2005) 0.90
West Nile virus encephalitis: an emerging disease in renal transplant recipients. Clin Transplant (2004) 0.83
Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med (2005) 7.54
Does Toll-like receptor 3 play a biological role in virus infections? Virology (2004) 2.73
Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol (2004) 2.71
West Nile virus neuroinvasive disease. Ann Neurol (2006) 2.42
Steroid-responsive encephalopathy associated with autoimmune thyroiditis and primary CNS demyelination. J Neurol Sci (2004) 2.35
Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol (2011) 1.83
Pediatric brainstem gangliogliomas show overexpression of neuropeptide prepronociceptin (PNOC) by microarray and immunohistochemistry. Pediatr Blood Cancer (2012) 1.57
Herpesvirus infections of the nervous system. Nat Clin Pract Neurol (2007) 1.48
Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev (2004) 1.42
Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system. Ann Neurol (2002) 1.38
Autosomal dominant diffuse leukoencephalopathy with neuroaxonal spheroids. Neurology (2000) 1.28
MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts. EMBO J (2003) 1.27
Glutathione binding to the Bcl-2 homology-3 domain groove: a molecular basis for Bcl-2 antioxidant function at mitochondria. J Biol Chem (2007) 1.26
Dual infections of the central nervous system with Epstein-Barr virus. J Infect Dis (2004) 1.24
Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors. J Neurovirol (2002) 1.23
Bell's palsy--is glucocorticoid treatment enough? N Engl J Med (2007) 1.22
West Nile virus meningoencephalitis. Nat Clin Pract Neurol (2006) 1.22
Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists. Arch Dermatol (2009) 1.19
Apoptosis in animal models of virus-induced disease. Nat Rev Microbiol (2009) 1.19
Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo. J Virol (2004) 1.18
Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels. J Virol (2002) 1.18
Use of PCR for the diagnosis of herpesvirus infections of the central nervous system. J Clin Virol (2002) 1.17
Two distinct phases of virus-induced nuclear factor kappa B regulation enhance tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in virus-infected cells. J Biol Chem (2003) 1.14
JNK regulates the release of proapoptotic mitochondrial factors in reovirus-infected cells. J Virol (2004) 1.13
Minocycline delays disease onset and mortality in reovirus encephalitis. Exp Neurol (2005) 1.11
Increasing plasmalogen levels protects human endothelial cells during hypoxia. Am J Physiol Heart Circ Physiol (2002) 1.10
Recurrent dermatomal vesicular skin lesions: a clue to diagnosis of herpes simplex virus 2 meningitis. Arch Neurol (2003) 1.09
Regional differences in viral growth and central nervous system injury correlate with apoptosis. J Virol (2004) 1.08
The uninvited guest: JC virus infection of neurons in PML. Neurology (2003) 1.05
Screening for critical illness polyneuromyopathy with single nerve conduction studies. Intensive Care Med (2014) 1.04
Reovirus-induced alterations in gene expression related to cell cycle regulation. J Virol (2002) 1.03
Progressive multifocal leukoencephalopathy: can we reduce risk in patients receiving biological immunomodulatory therapies? Ann Neurol (2010) 1.03
Novel strategy for treatment of viral central nervous system infection by using a cell-permeating inhibitor of c-Jun N-terminal kinase. J Virol (2007) 1.01
Progressive multifocal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of patients with and without AIDS. Arch Neurol (2002) 1.01
Central nervous system apoptosis in human herpes simplex virus and cytomegalovirus encephalitis. J Infect Dis (2002) 1.01
Reovirus-induced alteration in expression of apoptosis and DNA repair genes with potential roles in viral pathogenesis. J Virol (2003) 1.00
High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival. Neuro Oncol (2011) 1.00
Bone morphogenetic protein and retinoic acid-inducible neural specific protein-3 is expressed in gonadotrope cell pituitary adenomas and induces proliferation, migration, and invasion. Endocrinology (2006) 0.99
American Association of Neuromuscular & Electrodiagnostic Medicine evidenced-based review: use of surface electromyography in the diagnosis and study of neuromuscular disorders. Muscle Nerve (2008) 0.98
Danon disease presenting with dilated cardiomyopathy and a complex phenotype. J Hum Genet (2007) 0.98
Fas-mediated apoptotic signaling in the mouse brain following reovirus infection. J Virol (2009) 0.97
Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. J Neuropathol Exp Neurol (2001) 0.97
West Nile virus growth is independent of autophagy activation. Virology (2012) 0.97
JAK-STAT signaling pathways are activated in the brain following reovirus infection. J Neurovirol (2007) 0.95
Novel nuclear herniations induced by nuclear localization of a viral protein. J Virol (2004) 0.95
Nonstructural protein sigma1s is a determinant of reovirus virulence and influences the kinetics and severity of apoptosis induction in the heart and central nervous system. J Virol (2005) 0.95
Neuro-intensive care of patients with acute CNS infections. Neurotherapeutics (2012) 0.94
Reovirus infection of the CNS enhances iNOS expression in areas of virus-induced injury. Exp Neurol (2005) 0.94
Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. Arch Neurol (2009) 0.93
Daxx upregulation within the cytoplasm of reovirus-infected cells is mediated by interferon and contributes to apoptosis. J Virol (2013) 0.93
Intensive care unit-acquired weakness: implications for physical therapist management. Phys Ther (2012) 0.93
Colorado surveillance program for chronic wasting disease transmission to humans: lessons from 2 highly suspicious but negative cases. Arch Neurol (2007) 0.92
A brain slice culture model of viral encephalitis reveals an innate CNS cytokine response profile and the therapeutic potential of caspase inhibition. Exp Neurol (2011) 0.92
Paired overexpression of ErbB3 and Sox10 in pilocytic astrocytoma. J Neuropathol Exp Neurol (2006) 0.91
Inhibition of Rac GTPase triggers a c-Jun- and Bim-dependent mitochondrial apoptotic cascade in cerebellar granule neurons. J Neurochem (2005) 0.91
Death receptor-mediated apoptotic signaling is activated in the brain following infection with West Nile virus in the absence of a peripheral immune response. J Virol (2013) 0.91
Disrupted glutamate transporter expression in the spinal cord with acute flaccid paralysis caused by West Nile virus infection. J Neuropathol Exp Neurol (2009) 0.90
The proapoptotic Bcl-2 protein Bax plays an important role in the pathogenesis of reovirus encephalitis. J Virol (2011) 0.90
Initial management of acute bacterial meningitis in adults: summary of IDSA guidelines. Rev Neurol Dis (2006) 0.90
Novel approaches and challenges to treatment of central nervous system viral infections. Ann Neurol (2013) 0.90
Caspase-3 activation is required for reovirus-induced encephalitis in vivo. J Neurovirol (2010) 0.89
Proteomic analysis in the neurosciences. Mol Cell Proteomics (2002) 0.89
Pediatric adrenal cortical carcinoma: brain metastases and relationship to NF-1, case reports and review of the literature. J Neurooncol (2005) 0.88
McCune-Albright syndrome: surgical and therapeutic challenges in GH-secreting pituitary adenomas. J Neurooncol (2010) 0.88
Secondary central nervous system involvement by follicular lymphoma: case report and review of the literature. Surg Neurol (2006) 0.87
Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms. Cancer Gene Ther (2000) 0.86
Through a glass, darkly: cerebrospinal fluid viral load measurements and the pathogenesis of human immunodeficiency virus infection of the central nervous system. Arch Neurol (2002) 0.86
Viral infections of the nervous system, 2002: update on diagnosis and treatment. Arch Neurol (2002) 0.86
Type I interferon signaling limits reoviral tropism within the brain and prevents lethal systemic infection. J Neurovirol (2011) 0.85
Receptor expression, cytogenetic, and molecular analysis of six continuous human glioma cell lines. In Vitro Cell Dev Biol Anim (1998) 0.84
Experimental reovirus-induced acute flaccid paralysis and spinal motor neuron cell death. J Neuropathol Exp Neurol (2008) 0.83
Four decades of vascularized heterotopic cardiac transplantation in the mouse. J Invest Surg (2013) 0.83
Neuronal survival and cell death signaling pathways. Adv Exp Med Biol (2002) 0.83
Gefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastoma. Neuro Oncol (2013) 0.82
Using the Frontal Assessment Battery to identify executive function impairments in amyotrophic lateral sclerosis: A preliminary experience. Amyotroph Lateral Scler (2010) 0.81
TRAIL and inhibitors of apoptosis are opposing determinants for NF-kappaB-dependent, genotoxin-induced apoptosis of cancer cells. Oncogene (2002) 0.81
Down-regulation of cFLIP following reovirus infection sensitizes human ovarian cancer cells to TRAIL-induced apoptosis. Apoptosis (2007) 0.81
Clinical and molecular characteristics of congenital glioblastoma. Neuro Oncol (2012) 0.81
North American encephalitic arboviruses. Neurol Clin (2008) 0.81
Duplication within the SEPT9 gene associated with a founder effect in North American families with hereditary neuralgic amyotrophy. Hum Mol Genet (2009) 0.80
Issues and updates in emerging neurologic viral infections. Semin Neurol (2011) 0.80
Signal transducer and activator of transcription-5 mediates neuronal apoptosis induced by inhibition of Rac GTPase activity. J Biol Chem (2012) 0.79
Activation of innate immune responses in the central nervous system during reovirus myelitis. J Virol (2012) 0.79
Cardiac cell-specific apoptotic and cytokine responses to reovirus infection: determinants of myocarditic phenotype. J Card Fail (2009) 0.79
Human herpesvirus 6 and multiple sclerosis: the continuing conundrum. J Infect Dis (2003) 0.78
Spinal and cranial hypertrophic neuropathy in multiple sclerosis. Muscle Nerve (2005) 0.77
CD4 T cells mediate cardiac xenograft rejection via host MHC Class II. J Heart Lung Transplant (2012) 0.77
Elevated CSF cytokines in the Jarisch-Herxheimer reaction of general paresis. JAMA Neurol (2013) 0.77
Patterns of pulsatile pituitary glycoprotein secretion in central hypothyroidism and hypogonadism. J Clin Endocrinol Metab (1990) 0.77
Intralesionally implanted cisplatin cures primary brain tumor in rats. J Surg Oncol (1997) 0.77
Reduplicative paramnesia in Morvan's syndrome. J Neurol Sci (2007) 0.77
Type 3 reovirus neuroinvasion after intramuscular inoculation: viral genetic determinants of lethality and spinal cord infection. Virology (2002) 0.77
Pre-transplant presence of antibodies to MICA and HLA class I or II are associated with an earlier onset of bronchiolitis obliterans syndrome in lung transplant recipients. Clin Transpl (2012) 0.77
Pulsatile glycoprotein hormone secretion in glycoprotein-producing pituitary tumors. J Clin Endocrinol Metab (1991) 0.76
Arbovirus Infections. Continuum (Minneap Minn) (2015) 0.76
PML therapy: "It's Déjà vu all over again". J Neurovirol (2013) 0.76